Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Recent & Breaking News (TSX:VPH)

Valeo Pharma Announces That Hesperco(TM) Has Started Shipping

PR Newswire October 13, 2020

Valeo Pharma Reports its Third Quarter 2020 Results and Highlights

Canada NewsWire September 29, 2020

Valeo Pharma Begins Trading on the U.S. OTCQB Market

Canada NewsWire September 23, 2020

Valeo Pharma to Report Third Quarter 2020 Results and Hold Investors Conference Call / Webcast

PR Newswire September 23, 2020

Valeo Pharma Warrants to Begin Trading Today on CSE Under the Symbol VPH.WT.A

Canada NewsWire September 11, 2020

CSE Bulletin: New Listing - Valeo Pharma Inc. Warrants (VPH.WT.A)

Newsfile September 11, 2020

Valeo Pharma Announces Closing of Bought Deal Financing Including Exercise of Over-Allotment Option for Gross Proceeds of $6.9 Million

Canada NewsWire September 10, 2020

Valeo Pharma Receives Hesperco(TM) Natural Product License Approval From Health Canada

PR Newswire September 3, 2020

Valeo Pharma Has Submitted Hesperco(TM) Natural Product License Application for Approval to Health Canada

PR Newswire August 24, 2020

Specialty Pharma, Fintech, AI, AR, Ecomm & Cleantech Transport: CEOs of "NEXT SUPER STOCKS" dynaCERT, NexTech AR, Valeo Pharma, and Weyland Tech, Update Investors on Transformational Growth Trends

GlobeNewswire August 21, 2020

IIROC Trade Resumption - VPH

Canada NewsWire August 21, 2020

IIROC Trading Halt - VPH

Canada NewsWire August 20, 2020

Valeo Pharma Announces $6.0 Million Bought Deal Financing

Canada NewsWire August 20, 2020

BioNTech, CureVac, Valeo Pharma: Who is the Covid-19 Winner?

Mario Hose August 18, 2020

Valeo Pharma Commences Yondelis® Commercialization in Canada

Canada NewsWire August 12, 2020

Valeo Pharma Notifies Warrants Holders of Unchanged Expiry Date

Canada NewsWire August 5, 2020

Specialty Pharma, Telemedicine, Mobile Shopping & E-Wallets, Augmented Reality & Virtual Tradeshows. CEO's of NEXT SUPER STOCK presenters, Weyland Tech, CloudMD, NexTech AR, and Valeo Pharma Addressing Billion Dollar Market Opportunities

GlobeNewswire July 31, 2020

Valeo Pharma Applies for Listing on the U.S. OTCQB Market

Canada NewsWire July 29, 2020

Valeo Pharma to Present at Wall Street Reporter's Livestream Conference on July 29, 2020

PR Newswire July 28, 2020

Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop(TM)

Canada NewsWire July 13, 2020